Institutions Holding Call Options on Arbutus Biopharma Corp (ABUS)
This table provides information about the call option holders of Arbutus Biopharma Corp (ABUS). We have compiled data on the institutions that hold call options on the stock, with a total of 674,200 call options outstanding, which have been reported (via 13F filing form) to have a value of $2.22 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
244,600
calls
|
$804,734
0.0% of portfolio
|
N/A
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Feb 14, 2025 Q4 2024 |
175,000
calls
|
$575,750
0.01% of portfolio
|
N/A
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
150,000
calls
|
$493,500
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
50,400
calls
|
$165,816
0.0% of portfolio
|
N/A
|
|
|
Wolverine Trading, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
29,100
calls
|
$95,739
0.0% of portfolio
|
N/A
|
|
|
Gts Securities LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
21,200
calls
|
$69,748
0.0% of portfolio
|
N/A
|